In adults without coronary heart disease, DHA from algal oil lowered blood triglycerides and raised both HDL and LDL cholesterol in randomised trials.
Moderate certainty
Further research may change the size of the effect.Who this is about
adults without coronary heart disease
Practical note
Graded moderate: a meta-analysis of 11 randomised trials (485 healthy participants) with a pooled triglyceride change of -0.20 mmol/L, downgraded for small trials and imprecision; the much larger Cochrane review of long-chain omega-3, mostly from capsules, found a triglyceride effect at high certainty. The median algal DHA dose in the trials was 1.68 g a day, well above the amounts in the vegan status trials.
Safety note
The same trials showed a small rise in LDL cholesterol alongside the fall in triglycerides.
Sources
- Supports “DHA supplementation from algal oil, a marine source of (n-3) fatty acids not extracted from fish, may reduce serum TG and increase HDL-C and LDL-C in persons without coronary heart disease.” (Abstract) Bernstein AM, Ding EL, Willett WC, Rimm EB. 2012. Journal of Nutrition. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. publisher copyright; metadata and short quotes only; Courtesy of the U.S. National Library of Medicine
- Context “increasing LCn3 reduced triglycerides by ˜15% in a dose-dependent way (high-certainty evidence).” (Abstract, main results) Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L. 2020. Cochrane Database of Systematic Reviews. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Copyright The Cochrane Collaboration, published by John Wiley and Sons; metadata and short quotes only; Courtesy of the U.S. National Library of Medicine